Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients

BACKGROUND: Sclerostin is known to be a canonical Wnt/β-catenin signaling pathway inhibitor, while the Wnt/β-catenin signaling pathway is proposed to be involved in the development of arterial stiffness. This study aims to investigate the relationship between serum sclerostin levels and carotid–femo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yu-Chi, Hsu, Bang-Gee, Liou, Hung-Hsiang, Lee, Chung-Jen, Wang, Ji-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260557/
https://www.ncbi.nlm.nih.gov/pubmed/30482161
http://dx.doi.org/10.1186/s12872-018-0955-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260557/
https://www.ncbi.nlm.nih.gov/pubmed/30482161
http://dx.doi.org/10.1186/s12872-018-0955-5

Ejemplares similares